chevron_leftBack
S
As of 5 June 2026, Silexion Therapeutics Corp. has a market cap of $2.08M USD, ranking #47110 globally and #624 in Israel.
It ranks #4172 in the Healthcare sector, and #1322 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$2.08MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.1% | 21% | -21% | -70% | -84% | -97% |
News
Loading...
SLXN Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SLXN
ISIN: KYG1281K1489
Shares Out.:
Shares Outstanding:
418.995K1
Shares Float:
389.108K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
4.96 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SLGL
|
$231.51M
11K%
|
-
|
|
NASDAQ: MDWD
|
$209.11M
10K%
|
-
|
|
TLV: EPIT
|
$87.12M
4K%
251.95M ILS
|
-
|
|
NASDAQ: PYPD
|
$86.83M
4K%
|
-
|
|
NASDAQ: ENTX
|
$52.68M
2K%
|
-
|
|
TLV: REKA
|
$46.34M
2K%
134.01M ILS
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
37M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
26M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
17M%
|
97.4
|
|
SIX: RO
|
$324.68B
16M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
14M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
13M%
218.9B CHF
|
20.5
|
chevron_leftBack